Market Overview

Benzinga's Top #PreMarket Losers

What Investors Should Be Watching In The Antibiotic Space
Benzinga's Top Downgrades
Benzinga's Top Upgrades, Downgrades For January 9, 2017
Craving Packaged Food Stocks For 2017? RBC Serves Up 4 Buy-Rated Names
Pinnacle Foods updates guidance, plans refinancing (Seeking Alpha)

Durata Therapeutics (NASDAQ: DRTX) dipped 11.19% to $15.00 in pre-market trading. Durata Therapeutics confirmed the FDA approval of Dalvance to treat skin infections.

JinkoSolar Holding Co (NYSE: JKS) shares fell 9.13% to $23.50 in pre-market trading after the company reported weaker-than-expected first-quarter earnings.

Pinnacle Foods (NYSE: PF) dropped 6.88% to $30.98 in pre-market trading on proposed Pilgrim's Pride (NASDAQ: PPC) acquisition of Hilshire (NYSE: HSH).

Staples (NASDAQ: SPLS) shares dropped 2.15% to $11.40 in pre-market trading after the company named Frank Bifulco as Executive Vice President, Marketing. Analysts at Goldman Sachs downgraded Staples from Neutral to Sell and lowered the target price from $11.50 to $11.

Posted-In: PreMarket LosersNews Movers & Shakers Pre-Market Outlook Markets


Related Articles (HSH + DRTX)

View Comments and Join the Discussion!